Stephen Wargacki

Insider Reports History

Location
Warren, NJ
Signature
/s/ Lori Braender, as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Wargacki:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aquestive Therapeutics, Inc. Chief Science Officer Common Stock 343,552 $872,622 $2.54 10 Mar 2025 Direct
Aquestive Therapeutics, Inc. Chief Science Officer Non-Qualified Stock Option (right to buy) 65,000 07 Mar 2025 Direct
Aquestive Therapeutics, Inc. Chief Science Officer Non-Qualified Stock Option (right to buy) 56,250 07 Mar 2024 Direct

Insider Reports Filed by Stephen Wargacki

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AQST Aquestive Therapeutics, Inc. 07 Mar 2025 5 -$86,581 4 Chief Science Officer 11 Mar 2025, 17:49
AQST Aquestive Therapeutics, Inc. 10 May 2024 1 $0 4 Chief Science Officer 13 May 2024, 13:40
AQST Aquestive Therapeutics, Inc. 09 Mar 2024 1 -$95,184 4/A Chief Science Officer 02 Oct 2024, 14:15
AQST Aquestive Therapeutics, Inc. 09 Aug 2023 1 $0 4 SVP, Research & Development 09 Aug 2023, 16:30
AQST Aquestive Therapeutics, Inc. 05 May 2023 1 $0 4 SVP, Research & Development 05 May 2023, 16:00
AQST Aquestive Therapeutics, Inc. 10 Mar 2023 3 -$1,572 4 SVP, Research & Development 11 Mar 2024, 10:34
AQST Aquestive Therapeutics, Inc. 09 Mar 2023 1 $0 4 SVP, Research & Development 09 Mar 2023, 14:06
AQST Aquestive Therapeutics, Inc. 01 Jan 2023 0 $0 3 SVP, Research & Development 11 Jan 2023, 15:05